A. A. Krivulyak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. A. Krivulyak has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- A. R. Oskolkova
Sechenov University
1 shared publication - Aleksandr Davidovich Makatsariya
Sechenov University
1 shared publication - Anastasiia R. Komelkova
Sechenov University
1 shared publication - Antonina G. Solopova
Sechenov University
1 shared publication - Dmitry Vladislavovich Blinov
Federal Scientific and Clinical Center for Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency; Institute for Preventive and Social Medicine; Moscow Haass Medical Social Institute
1 shared publication - Grigoris Gerotziafas
Sechenov University
1 shared publication
Latest Publications
- Open Access
- 15 May 2026
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 20 (3) , 551-559
Recurrent severe preeclampsia and the risk of late cardiovascular complications
Preeclampsia (PE) is not only an acute obstetric complication but also a significant factor in long-term cardiovascular risk. This article analyzes the pathogenetic mechanisms linking recurrent severe PE with the development of chronic arterial hypertension, coronary heart disease, stroke, and heart failure in the long-term. Particular attention is paid to the two-stage PE model, as well as the key role for immune-inflammatory responses, oxidative stress, and hemostatic disorders. Recurrent PE is shown to cause cumulative damage to the vascular bed, transforming acute inflammation into chronic cardiovascular pathology. Neutrophil extracellular traps collectively resulting in innate immune activation, hypercoagulability, and endothelial damage, play a central role in the pathogenesis. Current approaches to preventing recurrent PE such as aspirin, calcium supplements, and low-molecular-weight heparins are discussed.
- 15 May 2026
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 20 (3) , 551-559
Open AccessRecurrent severe preeclampsia and the risk of late cardiovascular complications
Preeclampsia (PE) is not only an acute obstetric complication but also a significant factor in long-term cardiovascular risk. This article analyzes the pathogenetic mechanisms linking recurrent severe PE with the development of chronic arterial hypertension, coronary heart disease, stroke, and heart failure in the long-term. Particular attention is paid to the two-stage PE model, as well as the key role for immune-inflammatory responses, oxidative stress, and hemostatic disorders. Recurrent PE is shown to cause cumulative damage to the vascular bed, transforming acute inflammation into chronic cardiovascular pathology. Neutrophil extracellular traps collectively resulting in innate immune activation, hypercoagulability, and endothelial damage, play a central role in the pathogenesis. Current approaches to preventing recurrent PE such as aspirin, calcium supplements, and low-molecular-weight heparins are discussed.